Hepatitis B Vaccination in Chronic Kidney Disease: Review of Evidence in Non-Dialyzed Patients

作者: Alicja E. Grzegorzewska

DOI: 10.5812/HEPATMON.7359

关键词:

摘要: Context: Hepatitis B vaccination of hemodialysis patients is performed all over the world. There are also recommendations from world health organizations to vaccinate with chronic kidney disease (CKD) prior dialysis commencement, but imple­ mentation a hepatitis program less common and not well organized. Evidence Acquisition: This review article summarizes data indicating why, when how CKD before they start renal replacement therapy. Publication for this was bringing into being PubMed. Results: an agreement in nephrological societies among clinicians scientists that should be vaccinated early stages their disease, because higher glomerular filtration rate more likely associated responsive­ ness vaccination. Schedules optimal vaccine doses still investigated. Differences respect these problems may result com­ parisons various schedules without reference one

参考文章(92)
Iannacci Gr, Di Lullo L, Cecilia A, Gorini A, Polito P, Galderisi C, [Seroconversion and immune response after anti-HBV vaccination in patients on chronic hemodialysis: comparison of two vaccines]. Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia. ,vol. 28, pp. 525- ,(2011)
Somchai Eiam-Ong, Thaweesak Tirawatanapong, Kriang Tungsanga, Wanida Somboonsilp, Immune response of intradermal hepatitis B vaccination at lower dose versus intramuscular vaccination at double standard dose in predialytic chronic renal failure patients Journal of the Medical Association of Thailand Chotmaihet thangphaet. ,vol. 86, pp. 1122- 1127 ,(2003)
Karen Noakes, Mary Ramsay, David Salisbury, Immunisation against infectious disease TSO. ,(2006)
M. Chabaud, N. Depril, P. Cann, D. Leboulleux, R. Nandi, A-M. Coll-Seck, P. Coursaget, Detection of hepatitis B virus DNA by polymerase chain reaction in vaccinated and non-vaccinated Senegalese children Archives of virology. Supplementum. ,vol. 8, pp. 123- 131 ,(1993) , 10.1007/978-3-7091-9312-9_13
Ampol Mitrevej, Nuttanan Sinchaipanid, Wanpen Chaicumpa, Sunee Channarong, Kanchana Usuwantim, Kasem Kulkeaw, Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine. Asian Pacific Journal of Allergy and Immunology. ,vol. 25, pp. 233- 242 ,(2007)
Deloris E. Koziol, Harvey J. Alter, Paul V. Holland, John P. Kirchner, The Development of HBsAg-Positive Hepatitis Despite the Previous Existence of Antibody to HBsAg Journal of Immunology. ,vol. 117, pp. 2260- 2262 ,(1976)
D. R. Milich, F. V. Chisari, S. B. Kent, Alan McLachlan, G. B. Thorton, Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg. Journal of Immunology. ,vol. 137, pp. 315- 322 ,(1986)
M. Sutherland, A. Rashid, D. P. Sengar, W. A. McLeish, R. A. Couture, Hepatitis B antigen (HBAg) infection in a hemodialysis unit. I. HL-A8 and immune response to HBAg. Canadian Medical Association Journal. ,vol. 112, pp. 968- 971 ,(1975)